Pneumonia severity index: Difference between revisions
Jump to navigation
Jump to search
imported>Robert Badgett (Adapted and cleaned from WP and additions made) |
imported>Joe Quick m (subpages) |
||
| Line 1: | Line 1: | ||
{{subpages}} | |||
The '''[[pneumonia]] severity index''' (PSI) is a [[clinical prediction rule]] to estimate the probability of complications among patients with [[community acquired pneumonia]].<ref name="pmid8995086">{{cite journal |author=Fine MJ, Auble TE, Yealy DM, ''et al'' |title=A prediction rule to identify low-risk patients with community-acquired pneumonia |journal=N. Engl. J. Med. |volume=336 |issue=4 |pages=243–50 |year=1997 |pmid=8995086 |doi=}}</ref> | The '''[[pneumonia]] severity index''' (PSI) is a [[clinical prediction rule]] to estimate the probability of complications among patients with [[community acquired pneumonia]].<ref name="pmid8995086">{{cite journal |author=Fine MJ, Auble TE, Yealy DM, ''et al'' |title=A prediction rule to identify low-risk patients with community-acquired pneumonia |journal=N. Engl. J. Med. |volume=336 |issue=4 |pages=243–50 |year=1997 |pmid=8995086 |doi=}}</ref> | ||
| Line 13: | Line 14: | ||
*[http://pda.ahrq.gov/clinic/psi/psicalc.asp Pneumonia Severity Index Calculator] | *[http://pda.ahrq.gov/clinic/psi/psicalc.asp Pneumonia Severity Index Calculator] | ||
[[Category:Pneumonia]] | [[Category:Pneumonia]] | ||
Revision as of 21:33, 21 December 2007
The pneumonia severity index (PSI) is a clinical prediction rule to estimate the probability of complications among patients with community acquired pneumonia.[1]
The accuracy of the PSI has been independently validated by other researchers.[2]
A randomized controlled trial found that use of the PSI to guide management of community acquired pneumonia improved medical care by reducing resource consumption without reducing quality of care.[3]
The pneumonia severity index has been compared to the CURB-65 in predicting mortality.[2]
References
- ↑ Fine MJ, Auble TE, Yealy DM, et al (1997). "A prediction rule to identify low-risk patients with community-acquired pneumonia". N. Engl. J. Med. 336 (4): 243–50. PMID 8995086. [e]
- ↑ 2.0 2.1 Aujesky D, Auble TE, Yealy DM, et al (2005). "Prospective comparison of three validated prediction rules for prognosis in community-acquired pneumonia". Am. J. Med. 118 (4): 384-92. DOI:10.1016/j.amjmed.2005.01.006. PMID 15808136. Research Blogging.
- ↑ Marrie TJ, Lau CY, Wheeler SL, Wong CJ, Vandervoort MK, Feagan BG (2000). "A controlled trial of a critical pathway for treatment of community-acquired pneumonia. CAPITAL Study Investigators. Community-Acquired Pneumonia Intervention Trial Assessing Levofloxacin". JAMA 283 (6): 749-55. PMID 10683053. [e]